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Received 26 October 2012; received in revised form 6 November 2012; accepted 8 November 2012Table 1 Antibiotic susceptibility of Staphylococcus sap-
rophyticus isolates. Performance standards for antimicro-
bial susceptibility tests by Clinical and Laboratory Standards
Institute.3
Antimicrobial agents Susceptibility
of isolates
MIC (mg/dL)
Penicillin Resistant 0.5
Oxacillin Resistant 4
Clindamycin Susceptible 0.25
Levofloxacin Susceptible 0.5
Vancomycin Susceptible 1
Fusidic acid Intermediate 8
Trimethoprim-
sulfamethoxazole
Susceptible 20
Rifampin Susceptible 0.5
Teicoplanin Susceptible 2
Moxifloxacin Susceptible 0.25A 38-year-old healthy female patient attended our hospital
because of urinary urgency and frequency, with bilateral
flank pain (the right side was more severe than the left
side) and fever. Because urine analysis revealed blood
pyuria (white cell count(WBC) Z 99.8/high power
field(HPF), normal range <5/HPF), hematuria (RBC Z 16/
HPF, normal range <3/HPF), and a renal echogram
confirmed right pyelonephritis, a diagnosis of urinary tract
infection was made. Gentamicin 120 mg intravenous infu-
sion every 12 hours (maintenance dose was around 1.7 mg/
kg) was administered, after an initial loading dose of
gentamicin 120 mg (maintenance dose was 2 mg/kg).
Because the blood culture was Gram-positive cocci on the
3rd admission day, we contacted the staff at the clinical
microbiology laboratory for identification. After the fifth
gentamicin dose, the gentamicin trough level was found to
be 1.2 mg/mL, and the peak level was 5 mg/mL. The
patient’s fever subsided on the 3rd admission day. Blood
cultures (Vitek-2 system, bioMe´rieux, Marcy l’Etoile,
France) grew Gram-positive cocci, and Staphylococcus
saprophyticus was reported 2 days later. The test for
antibiotic susceptibility was reported (Vitek-2 system,
bioMe´rieux, Marcy l’Etoile, France) following the guidelines
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http://dx.doi.org/10.1016/j.jfma.2012.11.003Standards (Table 1). Her clinical symptoms gradually
improved. Follow-up laboratory data showed a WBC of
8400/mm3. A repeat renal sonogram showed resolution of
the pyelonephritis. A follow-up blood culture was sterile
and there was an absence of pyuria. She was givenLinezolid Susceptible 4
Tigecycline Susceptible 0.25
Gentamicin d 0.25
Chloramphenicol Resistant 64
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484 C.-H. Chengentamicin for 14 days, was discharged and had an
uneventful recovery.
S. saprophyticus is second only to Escherichia coli as
a causative organism of acute uncomplicated urinary tract
infection in young women.1 To date, only a few case reports
of S. saprophyticus bacteremia have been reported.1 We
report a patient with documented S. saprophyticus
bacteremia associated with pyelonephritis.
S. saprophyticus is generally susceptible to most antibi-
otics, including penicillin.2 Forrest et al have demonstrated
that failure rates for single-dose therapy are significantly
higher over 3- or 7-day regimens.2 In this case, we chose
gentamicin, because there was a good clinical response at
the time of empirical therapy (to better coverage of
commonly community-acquired uropathogens, including E.
coli, Klebsiella pneumoniae, and Proteus mirabilis) as well
as good renal concentration and resistance to some of b-
lactam antibiotics. In our clinical experience, the choice of
gentamicin to treat S. saprophyticus infection is one option.
In this case, we requested the staff of the clinical microbi-
ology laboratory to add in a gentamicinMIC test. The result ofthe gentamicin MIC was 1 mg/mL. We cannot interpret the
data based only on the MIC level, hence we judged the clin-
ical therapeutic effectiveness according to both the clinical
response and microbiological data. Careful interpretation of
susceptibility test reports should be undertaken.References
1. Choi SH, Woo JH, Jeong JY, Kim NJ, Kim MN, Kim YS, et al.
Clinical significance of Staphylococcus saprophyticus identified
on blood culture in a tertiary care hospital. Diagn Microbiol
Infect Dis 2006;56:337e9.
2. Forrest GN, Mehta S, Weekes E, Lincalis DP, Johnson JK,
Venezia RA. Impact of rapid in situ hybridization testing on
coagulase-negative staphylococci positive blood cultures.
J Antimicrob Chemother 2006;58:154e8.
3. Clinical and Laboratory Standards Institute. Performance stan-
dards for antimicrobial susceptibility tests; twenty-first infor-
mational supplement. Approved standard. CLSI document
M100-S21. 7th ed. Wayne, PA: Clinical and Laboratory Standards
Institute; 2011.
